Current Neuropharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.1 | Q1 | 88.2% | 1.642 | Q1 | 93.2% |
| 2024 | 5.3 | Q1 | 88.4% | 1.555 | Q1 | 92.7% |
| 2023 | 4.8 | Q1 | 85.8% | 1.299 | Q1 | 90.7% |
| 2022 | 5.3 | Q1 | 84.2% | 1.168 | Q1 | 89.5% |
| 2021 | 7.7 | Q1 | 93.4% | 1.722 | Q1 | 94.6% |
| 2020 | — | — | 1.955 | Q1 | 95.4% | |
| 2019 | — | — | 1.531 | Q1 | 92.9% | |
| 2018 | — | — | 1.490 | Q1 | 91.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1570-159X
ISSN
1875-6190
region
Middle East
coverage
2004-2026